Franklin Resources’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$796M Buy
28,341,834
+3,177,507
+13% +$84.6M 0.19% 111
2025
Q4
$627M Buy
25,164,327
+94,179
+0.4% +$2.37M 0.15% 139
2025
Q3
$639M Buy
25,070,148
+8,108,887
+48% +$200M 0.16% 139
2025
Q2
$411M Buy
16,961,261
+609,408
+4% +$14.2M 0.11% 189
2025
Q1
$414M Sell
16,351,853
-52,036
-0.3% -$1.36M 0.12% 183
2024
Q4
$435M Sell
16,403,889
-25,315
-0.2% -$687K 0.12% 180
2024
Q3
$478M Sell
16,429,204
-8,973,684
-35% -$262M 0.13% 174
2024
Q2
$711M Buy
25,402,888
+5,522,929
+28% +$152M 0.22% 114
2024
Q1
$552M Sell
19,879,959
-695,641
-3% -$19.3M 0.17% 143
2023
Q4
$592M Sell
20,575,600
-610,308
-3% -$18.4M 0.28% 86
2023
Q3
$703M Sell
21,185,908
-913,302
-4% -$32.3M 0.36% 67
2023
Q2
$811M Sell
22,099,210
-1,213,488
-5% -$47.2M 0.39% 55
2023
Q1
$951M Buy
23,312,698
+6,711,614
+40% +$290M 0.48% 43
2022
Q4
$851M Sell
16,601,084
-3,483,546
-17% -$167M 0.44% 49
2022
Q3
$879M Sell
20,084,630
-535,272
-3% -$26M 0.48% 44
2022
Q2
$1.08B Sell
20,619,902
-5,788,196
-22% -$295M 0.54% 37
2022
Q1
$1.37B Sell
26,408,098
-17,783,326
-40% -$923M 0.55% 34
2021
Q4
$2.61B Sell
44,191,424
-1,788,867
-4% -$88.6M 0.94% 9
2021
Q3
$1.98B Buy
45,980,291
+10,270,562
+29% +$455M 0.74% 14
2021
Q2
$1.4B Buy
35,709,729
+9,156,521
+34% +$356M 0.53% 39
2021
Q1
$962M Buy
26,553,208
+7,532,823
+40% +$267M 0.39% 63
2020
Q4
$700M Sell
19,020,385
-5,484,187
-22% -$201M 0.3% 88
2020
Q3
$853M Sell
24,504,572
-11,298,000
-32% -$396M 0.41% 58
2020
Q2
$1.31B Buy
35,802,572
+5,812,740
+19% +$197M 0.67% 27
2020
Q1
$929M Sell
29,989,832
-479,360
-2% -$16.3M 0.62% 33
2019
Q4
$1.13B Sell
30,469,192
-19,635
-0.1% -$699K 0.6% 31
2019
Q3
$1.04B Buy
30,488,827
+51,333
+0.2% +$1.87M 0.56% 35
2019
Q2
$1.25B Sell
30,437,494
-870,290
-3% -$34.6M 0.67% 23
2019
Q1
$1.26B Sell
31,307,784
-526,224
-2% -$21.1M 0.68% 23
2018
Q4
$1.32B Sell
31,834,008
-7,170,544
-18% -$298M 0.8% 17
2018
Q3
$1.63B Sell
39,004,552
-11,945,374
-23% -$460M 0.81% 14
2018
Q2
$1.75B Buy
50,949,926
+3,964,795
+8% +$135M 0.9% 13
2018
Q1
$1.58B Sell
46,985,131
-511,275
-1% -$17.6M 0.8% 16
2017
Q4
$1.63B Sell
47,496,406
-800,269
-2% -$27.3M 0.78% 13
2017
Q3
$1.64B Sell
48,296,675
-363,568
-0.7% -$11.7M 0.8% 15
2017
Q2
$1.55B Buy
48,660,243
+410,669
+0.9% +$13M 0.77% 16
2017
Q1
$1.57B Buy
48,249,574
+2,242,261
+5% +$70.7M 0.79% 17
2016
Q4
$1.42B Sell
46,007,313
-453,180
-1% -$13.8M 0.73% 20
2016
Q3
$1.49B Sell
46,460,493
-7,738,749
-14% -$259M 0.78% 17
2016
Q2
$1.81B Sell
54,199,242
-12,100,513
-18% -$386M 0.97% 10
2016
Q1
$1.86B Buy
66,299,755
+9,491,383
+17% +$271M 0.99% 11
2015
Q4
$1.74B Sell
56,808,372
-22,096,699
-28% -$695M 0.88% 12
2015
Q3
$2.35B Sell
78,905,071
-15,169,756
-16% -$486M 1.16% 6
2015
Q2
$2.99B Sell
94,074,827
-1,010,296
-1% -$32.9M 1.36% 2
2015
Q1
$3.14B Sell
95,085,123
-7,743,797
-8% -$246M 1.42% 3
2014
Q4
$3.04B Sell
102,828,920
-748,468
-0.7% -$21.5M 1.38% 5
2014
Q3
$2.91B Buy
103,577,388
+7,079,806
+7% +$199M 1.33% 4
2014
Q2
$2.72B Buy
96,497,582
+11,091,388
+13% +$316M 1.2% 7
2014
Q1
$2.6B Sell
85,406,194
-989,514
-1% -$29.5M 1.23% 6
2013
Q4
$2.51B Sell
86,395,708
-12,275,667
-12% -$357M 1.23% 5
2013
Q3
$2.69B Buy
98,671,375
+422,896
+0.4% +$11.5M 1.43% 3
2013
Q2
$2.61B Buy
+98,248,479
New +$2.71B 1.49% 3

Other funds holding PFE

Franklin Resources's PFE Position: Q1 2026 in Review

Franklin Resources increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $84.6M and bringing the position to 28,341,834 shares worth $796M. The position accounts for 0.19% of the portfolio, ranked #111.

Franklin Resources first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.14B in Q1 2015. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Franklin Resources held 28,341,834 shares of Pfizer worth $796M as of Q1 2026.
  • Franklin Resources bought 3,177,507 Pfizer shares in Q1 2026, an estimated $84.6M.
  • Pfizer made up 0.19% of Franklin Resources's portfolio in Q1 2026, its #111 holding.
  • Franklin Resources first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Franklin Resources's Pfizer position peaked at $3.14B in Q1 2015.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.